The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Triggering psoriasis: the role of infections and medications
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960
Nomura, I., Goleva, E., Howell, M. D., Hamid, Q. A., Ong, P. Y., Hall, C. F., Darst, M. A., Gao, B., Boguniewicz, M., Travers, J. B., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3262 · Cited by 731
Leung, D. Y., Harbeck, R., Bina, P., Reiser, R. F., Yang, E., Norris, D. A., Hanifin, J. M., & Sampson, H. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116711 · Cited by 519
Leung, D. Y., Gately, M., Trumble, A., Ferguson-Darnell, B., Schlievert, P. M., & Picker, L. J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.747 · Cited by 307
Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis.
Leung, D. Y., Travers, J. B., Giorno, R., Norris, D. A., Skinner, R., Aelion, J., Kazemi, L. V., Kim, M. H., Trumble, A. E., & Kotb, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118263 · Cited by 295
Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study
Gudjonsson, J. E., Thorarinsson, A. M., Sigurgeirsson, B., Kristinsson, K. G., & Valdimarsson, H. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05552.x · Cited by 249
Drugs in exacerbation of psoriasis
Abel, E. A., DiCicco, L. M., Orenberg, E. K., Fraki, J. E., & Farber, E. M. (1986) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(86)70265-x · Cited by 231
Österlund, A., Popa, R., Nikkilä, T., Scheynius, A., & Engstrand, L. (1997) · The Laryngoscope · doi:10.1097/00005537-199705000-00016 · Cited by 216
A Potential Role for Superantigens in the Pathogenesis of Psoriasis
Leung, D. Y. M., Walsh, P., Giorno, R., & Norris, D. A. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12468941 · Cited by 196
Tomi, N. S., Kränke, B., & Aberer, E. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.02.034 · Cited by 178
Drug-Induced Psoriasis: Recognition and Management
Tsankov, N., Angelova, I., & Kazandjieva, J. (2000) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200001030-00003 · Cited by 173
Fãvre, M., Orth, G., Majewski, S., Pura, A., Jabłońska, S., & Baloul, S. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00164.x · Cited by 171
JOHNSTON, A., GUDJONSSON, J. E., SIGMUNDSDOTTIR, H., LOVE, T. J., & VALDIMARSSON, H. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.00600.x · Cited by 159
Diluvio, L., Vollmer, S., Besgen, P., Ellwart, J. W., Chimenti, S., & Prinz, J. C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.7104 · Cited by 157
Secondary bacterial infections complicating skin lesions
Brook, I. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-10-808 · Cited by 121
Ramoz, N., Fãvre, M., Orth, G., Rueda, L.-A., & Bouadjar, B. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00536.x · Cited by 110
Improvement of Psoriasis of the Scalp With Ketoconazole
Rosenberg, E. W., & Belew, P. W. (1982) · Archives of Dermatology · doi:10.1001/archderm.118.6.370 · Cited by 101
Baroni, A., Paoletti, I., Ruocco, E., Agozzino, M., Tufano, M. A., & Donnarumma, G. (2003) · Journal of Cutaneous Pathology · doi:10.1046/j.0303-6987.2004.0135.x · Cited by 99
Lithium Compound Treatment and Psoriasis
Skoven, I. (1979) · Archives of Dermatology · doi:10.1001/archderm.1979.04010100005003 · Cited by 96
Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod
Fanti, P. A., Dika, E., Vaccari, S., Miscial, C., & Varotti, C. (2006) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2006.02980.x · Cited by 96
Cutaneous Adverse Effects of Lithium: Epidemiology and Management
Yeung, C. K., & Chan, H. H. L. (2004) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200405010-00002 · Cited by 91
A Review and Controlled Study of Cutaneous Conditions associated with Lithium Carbonate
Sarantidis, D., & Waters, B. G. H. (1983) · The British Journal of Psychiatry · doi:10.1192/bjp.143.1.42 · Cited by 90
RESPONSE OF SCALP PSORIASIS TO ORAL KETOCONAZOLE
Farr, P. M., Marks, J., Krause, L., & Shuster, S. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90853-0 · Cited by 90
Hohenadl, C., Germaier, H., Walchner, M., Hagenhofer, M., i, M. H., Stürzl, M., Kind, P., Hehlmann, R., Erfle, V., & Leib‐Mösch, C. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00728.x · Cited by 88
Patch Tests With Killed Sonicated Microflora in Patients With Psoriasis
LOBER, C. W., Belew, P. W., Rosenberg, E. W., & Bale, G. (1982) · Archives of Dermatology · doi:10.1001/archderm.1982.01650170036019 · Cited by 80
The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis.
O’Brien, M., & Koo, J. Y. M. (2006) · PubMed · Cited by 77
Drug Exposure and Psoriasis Vulgaris: Case‐Control and Case‐Crossover Studies
Cohen, A. D., Bonneh, D. Y., Reuveni, H., Vardy, D., Naggan, L., & Halevy, S. (2005) · Acta Dermato Venereologica · doi:10.1080/00015550510032823 · Cited by 76
Weißenborn, S. J., Pfister, H., Fuchs, P. G., Höpfl, R. M., Weber, F., & Smola, H. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00641.x · Cited by 72
The Relationship of Lithium Carbonate to Psoriasis
Carter, T. N. (1972) · Psychosomatics · doi:10.1016/s0033-3182(72)71404-8 · Cited by 71
Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis
Travers, J. B., Hamid, Q. A., Norris, D. A., Kuhn, C. A., Giorno, R. C., Schlievert, P. M., Farmer, E. R., & Leung, D. Y. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6835 · Cited by 71
Molinari, G., & Chhatwal, G. S. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)80010-1 · Cited by 69
A new endogenous retroviral sequence is expressed in skin of patients with psoriasis
Molès, J., Tesnière, A., & Guilhou, J. J. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06555.x · Cited by 68
Incidence ofCandidain psoriasis – a study on the fungal flora of psoriatic patients
Waldman, A., Gilhar, A., Duek, L., & Berdicevsky, I. (2001) · Mycoses · doi:10.1046/j.1439-0507.2001.00608.x · Cited by 68
Guttate psoriasis associated with perianal streptococcal disease
Honig, P. J. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80577-8 · Cited by 61
High-resolution structure ofmyo-inositol monophosphatase, the putative target of lithium therapy
Gill, R. S., Mohammed, F., Badyal, R., Coates, L., Erskine, P. T., Thompson, D., Cooper, J. B., Gore, M. G., & Wood, S. P. (2005) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905004038 · Cited by 59
Bessis, D., Molès, J., Basset‐Séguin, N., Tesnière, A., Arpin, C., & Guilhou, J. J. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06116.x · Cited by 51
Fungal Flora of Human Faeces in Psoriasis and Atopic Dermatitis
Buslau, M., Menzel, I., & Holzmann, H. (1990) · Mycoses · doi:10.1111/myc.1990.33.2.90 · Cited by 50
Allan, S. J., Kavanagh, G. M., Herd, R. M., & Savin, J. A. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.05822.x · Cited by 50
Elevated Levels of the Endogenous Retrovirus ERV3 in Human Sebaceous Glands
Andersson, A., Mérza, M., Venables, P. J., Pontén, F., Sundström, J., Cohen, M., & Larsson, E. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12329612 · Cited by 49
Dika, E., Varotti, C., Bardazzi, F., & Maïbach, H. I. (2006) · Cutaneous and Ocular Toxicology · doi:10.1080/15569520500536568 · Cited by 47
A VIRUS‐LIKE PARTICLE ASSOCIATED WITH PSORIASIS
Dalen, A., Hellgren, L. I., Iversen, O., & Vincent, J. (1983) · Acta Pathologica Microbiologica Scandinavica Section B Microbiology · doi:10.1111/j.1699-0463.1983.tb00037.x · Cited by 44
Foerster, J., Nolte, I. M., Junge, J., Bruinenberg, M., Schweiger, S., Spaar, K., van der Steege, G., Ehlert, C., Mulder, M. J., Kalscheuer, V. M., et al. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23504.x · Cited by 37
Ockenfels, H. M., Wagner, S. N., Keim-Maas, C., Funk, R., Nussbaum, G., & Goos, M. (1996) · Archives of Dermatological Research · doi:10.1007/bf02505220 · Cited by 36
Is Human Papillomavirus Type 5 the Putative Autoantigen Involved in Psoriasis?
Majewski, S., Jabłońska, S., Fãvre, M., & Orth, G. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00310.x · Cited by 31
Incidental detection of S. pyogenes-DNA in psoriatic skin by PCR
Weisenseel, P., & Prinz, J. C. (2005) · Archives of Dermatological Research · doi:10.1007/s00403-005-0559-7 · Cited by 28
Does Pityrosporum Ovale Have a Role in Psoriasis?
Elewski, B. E. (1990) · Archives of Dermatology · doi:10.1001/archderm.126.8.1111 · Cited by 25
Stevens, R. W., Baltch, A. L., Smith, R. P., McCreedy, B. J., Michelsen, P. B., Bopp, L. H., & Urnovitz, H. B. (1999) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.6.6.783-786.1999 · Cited by 24
High prevalence of an IgG response against murine leukemia virus (MLV) in patients with psoriasis
Molès, J., Hadi, J.-C., & Guilhou, J. (2003) · Virus Research · doi:10.1016/s0168-1702(03)00137-0 · Cited by 21
Senff, H., Bothe, C., Busacker, J., et al. (1990) · Mycoses · doi:10.1111/myc.1990.33.1.29 · Cited by 18
Knijff, E. M., Kupka, R., Ruwhof, C., et al. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00214.x · Cited by 18
[Cutaneous lesions due to lithium therapy (author's transl)].
Lambert, D., Beer, F., Gisselman, R., Bouilly, D., & Jl, C. (1982) · PubMed · Cited by 14
Harwell, W. B. (1983) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(83)80153-4 · Cited by 14
Endogene retrovirale Sequenzen als Faktor in der Pathogenese des systemischen Lupus erythematodes
Walchner, M., Leib‐Mösch, C., Messer, G., & Kind, P. (1996) · Der Hautarzt · doi:10.1007/s001050050460 · Cited by 8
Cited by
Boehncke, W.-H., & Schön, M. P. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61909-7 · Cited by 2,542
Psoriasis Pathogenesis and Treatment
Rendon, A., & Schäkel, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061475 · Cited by 2,064
Risk Factors for the Development of Psoriasis
Kamiya, K., Kishimoto, M., Sugai, J., Komine, M., & Ohtsuki, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184347 · Cited by 640
The emerging world of the fungal microbiome
Huffnagle, G. B., & Noverr, M. C. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.04.002 · Cited by 567
The Gut Microbiota in Immune-Mediated Inflammatory Diseases
Forbes, J. D., Van Domselaar, G., & Bernstein, C. N. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01081 · Cited by 429
Metadata
- Authors
- Fry, L., & Baker, B. S.
- Venue
- Clinics in Dermatology
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 25
- Issue
- 6
- Pages
- 606-615
- ISSN
- 0738-081X (ISSN-L)
- OpenAlex
- W2061326479
- Cited by
- 384
- References
- 54
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.